BREASTOX
LIVE

Serial Number

99715466

Owner

Mira DX, Inc.

Attorney

Jessica L. Rothstein

Filing Date

Mar 20, 2026

Add to watchlist:

No watchlists yet
View on USPTO

BREASTOX Trademark

Serial Number: 99715466

BREASTOX is a trademark filed by Mira DX, Inc. on March 20, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Mira DX, Inc. (7 trademarks)

Suite 2410
Los Angeles, CA 90025

Entity Type: 03

Trademark Details

Filing Date

March 20, 2026

Registration Date

Not Registered

Goods & Services

Specimen collection kits for the collection of saliva for use in DNA screening and genetic testing for medical purposes comprised primarily of swabs, collection tubes with caps, all with or without stabilizing reagents and with instructions, printed mailing labels and flat pack cardboard mailing boxes

Specimen collection kits for use in genetic testing comprised primarily of saliva containers for medical purposes sold empty, instructions, shipping labels and transport packaging; Medical diagnostic apparatus for testing and analysis of DNA and genetic samples for medical purposes; Medical specimen collection devices in the nature of empty tubes and vials for the collection of DNA samples for use in medical testing and analysis of genetics; Saliva collection devices for medical purposes

Research and development for the purpose of determining treatment selection for breast cancer

DNA collection kit comprised of DNA collection laboratory swab and swab handle

Medical and laboratory analysis in connection with the treatment of patients; Processing medical test kits and home sample collection kits; medical testing of saliva and blood; Medical testing for diagnostic or treatment purposes; Genetic testing for medical purposes; medical testing for predicting toxicity in connection with radiation treatments; Medical consultancy services; Medical risk assessment services in the nature of predicting toxicity in connection with radiation treatments

Filing History

APPLICATION FILING RECEIPT MAILED
Mar 20, 2026 MAFR
NEW APPLICATION ENTERED
Mar 20, 2026 NWAP